Screening Techniques in Doping Analysis by GC/MS
Applications | | ShimadzuInstrumentation
Drug doping undermines fair competition and athlete health and requires sensitive analytical methods to ensure compliance with regulations set by bodies such as WADA.
This article reviews screening techniques for detecting prohibited substances using gas chromatography mass spectrometry (GC/MS). It focuses on Screening Method No.2, designed for compounds that are difficult to volatilize, exemplified by cocaine metabolites.
The pretreatment workflow involves acid hydrolysis, liquid-liquid extraction, pH adjustment and derivatization using MSTFA and MBTFA to enhance volatility.
The analysis employs a Shimadzu GCMS-QP2010 with a DB-5 column (15 m×0.25 mm×0.25 µm) under a temperature program from 100 °C to 300 °C and scan range m/z 50–550.
Detection limits meet the WADA MRPL of 0.5 µg/mL. The method displays clear chromatographic peaks for target analytes and their metabolites. Side-by-side presentation of chromatograms for parent and metabolite ions facilitates rapid assessment. Quality control includes drug-free and blank samples to confirm method reliability.
This GC/MS approach provides a robust, reproducible screening tool for nonvolatile doping agents in biological samples. It supports routine laboratory workflows in anti-doping agencies and sports medicine.
Advances may include coupling with high-resolution MS for broader screening of designer drugs, automation of sample preparation, and AI-assisted data interpretation. Extension to peptide hormones and isotopic ratio analysis can further strengthen anti-doping capabilities.
Screening Method No.2 illustrated here achieves reliable detection of difficult-to-volatile drugs, reinforcing the value of GC/MS in sports anti-doping testing.
WADA Technical Document TD2004MRPL
GC/MSD, GC/SQ
IndustriesForensics
ManufacturerShimadzu
Summary
Importance of Topic
Drug doping undermines fair competition and athlete health and requires sensitive analytical methods to ensure compliance with regulations set by bodies such as WADA.
Objectives and Study Overview
This article reviews screening techniques for detecting prohibited substances using gas chromatography mass spectrometry (GC/MS). It focuses on Screening Method No.2, designed for compounds that are difficult to volatilize, exemplified by cocaine metabolites.
Methodology and Instrumentation
The pretreatment workflow involves acid hydrolysis, liquid-liquid extraction, pH adjustment and derivatization using MSTFA and MBTFA to enhance volatility.
- Add 6 M HCl to urine and heat at 105 °C for hydrolysis
- Extract with diethyl ether after pH adjustment to 9.6
- Derivatize with MSTFA and MBTFA at 80 °C
The analysis employs a Shimadzu GCMS-QP2010 with a DB-5 column (15 m×0.25 mm×0.25 µm) under a temperature program from 100 °C to 300 °C and scan range m/z 50–550.
Main Results and Discussion
Detection limits meet the WADA MRPL of 0.5 µg/mL. The method displays clear chromatographic peaks for target analytes and their metabolites. Side-by-side presentation of chromatograms for parent and metabolite ions facilitates rapid assessment. Quality control includes drug-free and blank samples to confirm method reliability.
Benefits and Practical Applications
This GC/MS approach provides a robust, reproducible screening tool for nonvolatile doping agents in biological samples. It supports routine laboratory workflows in anti-doping agencies and sports medicine.
Future Trends and Potential Applications
Advances may include coupling with high-resolution MS for broader screening of designer drugs, automation of sample preparation, and AI-assisted data interpretation. Extension to peptide hormones and isotopic ratio analysis can further strengthen anti-doping capabilities.
Conclusion
Screening Method No.2 illustrated here achieves reliable detection of difficult-to-volatile drugs, reinforcing the value of GC/MS in sports anti-doping testing.
Reference
WADA Technical Document TD2004MRPL
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Fast and Comprehensive Doping Agent Screening in Urine by Triple Quadrupole GC/MS
2011|Agilent Technologies|Applications
Fast and Comprehensive Doping Agent Screening in Urine by Triple Quadrupole GC/MS Application Note Forensic Toxicology Authors Abstract Peter van Eenoo, Wim Van Gansbeke Nik De Brabanter, Koen Deventer A rapid analytical method was developed on the Agilent 7000 Series…
Key words
excr, excrmrpl, mrpltransitions, transitionsandrosterone, androsteroneprohibited, prohibitedparent, parentsubstances, substancesetiocholanolone, etiocholanolonedoping, dopingtms, tmswada, wadasubstance, substancemethod, methodcollision, collisionendogenous
How do isotope fingerprints support doping control investigations?
2018|Thermo Fisher Scientific|Guides
Isotope Ratio Mass Spectrometry SmartNotes How do isotope fingerprints support doping control investigations? While motivated to mark new records with each competition, athletes are more than ever aware of anti-doping policies, rules and regulations. Authorities depend on accurate analysis without…
Key words
isotope, isotopedoping, dopingcarbon, carbonirms, irmsfingerprints, fingerprintssteroids, steroidsanabolic, anabolicfingerprint, fingerprintandrogenic, androgenicwada, wadacontrol, controlcompounds, compoundsmetabolites, metabolitesinvestigations, investigationswhat
Screening Analysis of Steroid Profiles and Qualitative Doping Substances by GC-MS/MS
2022|Shimadzu|Applications
Application Note No. 77A Screening Analysis of Steroid Profiles and Qualitative Doping Substances by GC-MS/MS Masato Okano*1 , Mitsuhiko Sato*1, Yuma Watanabe*1, Yuki Nakagawa *2, Yuki Sakamoto *2 Life Science Life Science Abstract There are two notable trends in…
Key words
games, gamesmrpl, mrpltms, tmsblank, blankdoping, dopingmetabolite, metabolitewada, wadajuly, julyaccredited, accreditedandrosterone, androsteronesubstances, substancesnote, noteratio, ratioospemifene, ospemifeneapplication
Extend the time window for the detection of low level anabolic‑androgenic steroids and their metabolites
2018|Agilent Technologies|Applications
Application Note Doping Control Extend the time window for the detection of low level anabolic‑androgenic steroids and their metabolites Steroid profiling, screening, and confirmatory analysis using the Agilent 7010 GC/MS mass spectrometer Author Joachim Grosse Institute of Doping Analysis and…
Key words
doping, dopingtestosterone, testosteroneetiocholanolone, etiocholanoloneandrosterone, androsteronesteroid, steroidwada, wadaabundance, abundancenonconjugated, nonconjugatedepitestosterone, epitestosteronemarkers, markersendogenous, endogenousbackflush, backflushexogenous, exogenousanabolic, anabolicmoiety
